Answers are grounded in this paper and cite their sources.
In the 1970s andrology really emerged as a specific discipline. The American Society of Andrology (ASA) was founded in 1975. In 1978, under the guidance of Dr Rune Eliasson, publication of the International Journal of Andrology was initiated, and in 1992 it became the official journal of the European Academy of Andrology (EAA). In 1980, the ASA began publication of the Journal of Andrology under the editorship of Dr Andrzej Bartke (Burnett et al, 2012). In addition to these, 3 other journals specifically devoted to andrology are also currently published. Andrology originally was a branch of medicine treating health issues specific to males with a focus on their reproductive system, and included studies of the gonadal, endocrine, and accessory organ systems, and diagnosis and treatment of medical conditions related to fertility, sexual function, and the urogenital system. The ASA has taken a broad view and has promoted and supported basic research on model organisms that leads to an understanding of the mechanisms underlying these systems. In addition, there are parallels between research applicable to human fertility and the reproduction of animal species important for economic or conservation purposes; significant publications in these areas are also included in the Journal of Andrology. Since 1980, there have been huge advances in biomedical science in general, and in aspects that particularly apply to andrology. Molecular biology and genome sequencing has led to the knowledge of genes that affect the development of the reproductive organs, male fertility, and disorders of the reproductive system. The addition of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) to the repertoire of assisted reproductive technologies (ART) has overcome major barriers to male infertility. Although they have diminished the importance of andrology research in aspects of sperm characteristics related to fertilizing ability, such as motility, because they bypass the natural barriers, the widespread use of such techniques has increased the need for andrology lab facilities as a component of such procedures and spawned research into genetic and epigenetic consequences of eliminating this natural selection process. Examination of papers with high citation rates in the Journal of Andrology over the life of the journal provides a measure of the areas to which the journal has made significant contributions to the field of andrology (Table). Some of those areas may have had more impact on the development of the field of andrology over the past 32 years and others are very highly relevant to current and future issues in andrology. Although this list does not cover all the areas of contribution of the journal to the progress in andrology, and citation rates do not always give a full measure of the impact of articles, this selection nevertheless highlights areas in which the Journal of Andrology has published numerous significant studies and reviews, and honors the contributions of the authors. Papers in the area of oxidative stress in spermatozoa and also in testes were in general the most highly cited (Alvarez et al, 1987; Aitken and Clarkson, 1988; de Lamirande and Gagnon, 1992; Saleh and Agarwal, 2002; Turner and Lysiak, 2008). The studies in the Journal of Andrology defined mechanisms and emphasized the relationship between the generation of reactive oxygen species in the testis and sperm with infertility. Modulating reactive oxygen species generation offers the hope of improving testicular function and semen quality. Currently there is much activity in using relatively common oral, readily available antioxidant therapies for treatment of male infertility, both for the purpose of achieving natural pregnancies and in ART procedures (Aitken et al, 2012). Although these therapies have oftenbeenshowntoachieve better sperm function and improve pregnancy rates, appropriate placebo-controlled clinical trials have not been performed and are still needed; trials with these antioxidants should be an important area for future research. The next category of numerous highly cited papers involved analysis of sperm chromatin and relationship to semen quality and fertility. Since the advent of IVF and ICSI, the focus of semen analysis has expanded from just the motility and acrosomal properties of the spermatozoa necessary for accessing and fusing with the oocyte to a more detailed analysis of the quality of the sperm's genetic material that is delivered. This concern has been heightened by the fact that in ART, defective sperm that might be carrying more genetic damage can be used for successful fertilization, transmitting the genetic defect to the next generation. Indeed, sperm with poor semen quality by classical criteria did display DNA-strand breakage by the comet and in situ nick-translation assays (Irvine et al, 2000). The description of a rapid and practical flow cytometric assay for quantifying DNA strand breakage and chromatin packaging abnormalities in large numbers of sperm by the sperm chromatin structure assay (SCSA) in an Andrology Lab Corner paper provided a description of background and protocols to enable this assay to be more widely used in many andrology labs, where it now is a important part of semen evaluation (Evenson et al, 2002). Furthermore, this assay has proven valuable in environmental epidemiology studies on the potential impact of pollution on male reproductive health. Comparison of the different assays with others such as terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and sperm chromatin dispersion (SCD) demonstrated a good correlation between the SCSA, TUNEL, and SCD assays, and these could be used to assess sperm DNA damage, which is higher in infertile than in fertile males (Chohan et al, 2006). Although there is general agreement on the association between sperm DNA damage and infertility, the presence or absence of such damage does not absolutely distinguish fertile from infertile individuals; an excellent discussion of the value and limitations of those tests for patients undergoing specific procedures, including intrauterine insemination, IVF, and ICSI, was presented in a very useful review in the Journal of Andrology(Zini and Sigman, 2006). An animal study has been successfully used to experimentally test the level of DNA damage that causes failure of embryo development and determine the stage of embryo development at which developmental defects predictive of blastocyst apoptosis can be observed (Fatehi et al, 2006); these methods can be used to select more viable embryos in human ART procedures. Finally, a well-cited paper (Aoki et al, 2006) describing variation in protamine levels in infertile men has portended greatly increased interest in the roles in embryogenesis of epigenetic factors including DNA methylation, the presence of and localization of specific residual histones on the chromatin, and the presence of activating and repressive posttranslational modifications of these histones. One of the most highly cited papers in the Journal of Andrology(Hammerstedt et al, 1990) was in the area of semen cryopreservation and involved an in-depth analysis of the membrane properties of sperm and how that affected the survival of the cells during a freeze-thaw cycle. Further studies into the initiation of capacitation-like (Bailey et al, 2000) and apoptotic-like (Ortega-Ferrusola et al, 2008) reactions as a result of the freeze-thaw cycle and their roles in the reduced life spans of the surviving populations have been widely cited. Although the data in these papers were based largely on bull, ram, and equine sperm, as semen cryopreservation and artificial insemination are economically important in those species, the general principles elucidated are also applicable to improving the cryopreservation of human sperm, which is assuming new importance with the need to preserve the viability and DNA integrity of the low numbers of testicular sperm obtained from testicular biopsies of azoospermic men. The Journal of Andrology has published well-cited studies relating the current increases in obesity and type 2 diabetes to disorders of the male reproductive and genital systems. One such study demonstrated that increased body mass index was associated with a dramatic decrease in the numbers of normal motile sperm cells and also a decrease in sperm integrity (Kort et al, 2006). Because obesity is now considered as one factor comprising metabolic syndrome, a more recent review (Traish et al, 2009) suggested that hypogonadism (specifically androgen deficiency) was associated with and might be responsible for an increase in metabolic syndrome, and furthermore that erectile dysfunction may be a consequence of the metabolic syndrome. Both the Journal of Andrologyand the International Journal of Andrology have published important, widely used recommendations resulting from collaborations between several societies to carefully outline the patient assessment and response criteria for evaluating the benefits and risks of testosterone therapy for late-onset hypogonadism appearing in aging males (Nieschlag et al, 2005, 2006; Wang et al, 2009). The mechanisms that account for age-related declines in testosterone and therapeutic hormone replacement approaches continue to be an active area of study (Zirkin and Tenover, 2012). The Journal of Andrology has also published several well-cited studies supporting the use of phosphodiesterase-5 inhibitors for treatment of erectile dysfunction (Guay et al, 2001; Hellstrom et al, 2002), as well as numerous basic research studies of mechanisms involved. Recent advances and new challenges on this topic are discussed by Burnett and Hellstrom (2012). The Journal of Andrology and the International Journal of Andrology have similar scopes and impact factors, but also have historically had unique areas of emphasis. Some particularly strong areas that are emphasized more in the International Journal of Andrology include effects of environmental toxicants and endocrine disruptors on development of the gonads and the male accessory organs and the consequences of this disruption on pubertal development, fecundity, and malignancy; pathogenesis of testicular germ cell cancer; and studies of genetic causes (eg, Y-chromosomal defects) in infertility. Conversely, the Journal of Andrology has had a greater breadth of basic science studies and animal model studies. To draw from the strengths of the 2 journals, the ASA and EAA will merge them to form a new journal, Andrology, which has begun accepting submissions and will publish its first issue in January 2013 (Meistrich and Huhtaniemi, 2012). The major motivation for the merging of the Journal of Andrologyand the International Journal of Andrology is to strengthen and improve the quality of the new merged journal. Rather than continuing in a competitive mode between the top 2 journals, the goal of the merger is to establish Andrology as the clear leading publication for studies on male reproductive science and medicine. It is the goal of the societies and editors that the merger will establish a clear first-choice journal in the field of andrology that will effectively compete with journals in related disciplines and enhance the perception of the field of andrology. With a broader base of papers to draw from, it is hoped that the quality of papers published will clearly reflect a high level of scientific investigation that will foster attention and respect for the field of andrology, thus helping to facilitate further growth and development in the field of andrology. The editorial team, composed of co–editors-in-chief from North America and Europe and associate editors and editorial board members from 6 continents and 22 different countries, carefully selected to represent all areas of study relevant to andrology, reflects the intention of establishing a truly global journal. Although the merger provides a stronger foundation to build upon, an improvement of the stature and impact factor of the journal is not automatic, and will be contingent on Andrology successfully navigating through challenges and obstacles, some of which are reflective of the current state of scientific journal publishing and some of which are specific to the merger and launching of a new journal. For example, the dramatic advances in electronic publishing, which facilitate more rapid submission, editing, and publishing of manuscripts, has enabled the launching of new journals, evidenced by the abundance of new, “low-impact” journals in many areas of biomedicine, including andrology. So there will be, and already is, a line of new journals ready to fill the void left by the Journal of Andrologyand the International Journal of Andrology. Therefore, it is imperative that Andrology establish itself quickly and firmly as the journal of choice for top manuscripts in the field. The journal oversight committee, the editors, the editorial board, and the publisher, Wiley-Blackwell, will work hard to advance the journal by improving the review and editing process, enhancing the appearance and functionality of the journal, maximizing accessibility consistent with a business model to recoup costs, and striving to assure the highest level of publishing integrity and fairness to authors. However, ultimately the success of the journal is dependent on the submission of top-quality papers, especially by members of the ASA and EAA. To increase the visibility and usability of the new journal, the editors are working closely with the EAA and ASA publications committees, the latter chaired by Jacques Tremblay, to enhance the flow of information from the journal through social media sites to society members and the public. Such efforts will include the highlighting of breakthrough manuscripts and online discussion of manuscripts. We expect that Andrology will be the leading publication in new developing areas of andrology. Although it is impossible to predict future breakthroughs in andrology, certain fields of study seem to portend high impact in the future. For example, it is likely that there will be major advances in the genetics of infertility through complete genome sequencing of patients and controls, which will uncover structural variations and rare polymorphisms that likely account for a high percentage of male infertility (de Rooij and Griswold, 2012). These genetic tools may benefit other areas of andrology as well. Similarly, studies of epigenetic alterations have the potential to demonstrate the role of the environment and drastically advance our understanding of diseases of the reproductive tract, including cancer and infertility. Another example of a potentially major advance in the treatment of reproductive diseases is the ongoing growth of stem cell biology and technology. The basic concepts in characterizing mammalian germ cell stem cells were clearly explained to a wide audience in a highly cited paper by de Rooij and Russell (2000), which contributed to an increase in research and outstanding progress in this area over the last decade. Nevertheless, challenges continue (de Rooij and Griswold, 2012). Stem cell studies have the potential of dramatically enhancing our knowledge of basic biological mechanisms, as well as the hope for of new treatment modalities. Such therapeutic benefits could benefit numerous areas of andrology, from improved options for patients attempting fertility preservation prior to cancer therapies to addressing various forms of abnormal spermatogenesis. The field of ART may be an area that will benefit from recent technological advances in sperm selection procedures and sperm cryopreservation. There appear to be promising new techniques to select sperm for ICSI that contain less DNA damage than unselected sperm in the ejaculate. As our understanding of what makes a sperm competent for normal embryogenesis increases, sperm selection may become a key topic of andrology research. Also, the recent advances in recovering sperm from testicular biopsies in men with nonobstructive azoospermia have highlighted the need for enhanced sperm cryopreservation techniques for these patients with limited sperm. Sperm vitrification may be one tool for improving cryopreservation success in these men and in severely oligozoospermic patients. Lastly, it is likely that novel pharmaceutical advances, ultimately based on progress in pharmacogenetics, will alter the way sexual dysfunction and other disorders of the male reproductive system are treated. Underscoring all the potential clinical applications will be the continued progress of understanding cellular and endocrine biology, and technological advances in cell analysis, cell separation techniques, genomics, and proteomics. Andrology stands ready to publish in all areas of male reproductive studies and will anxiously await the next breakthroughs and major contributions. The Journal of Andrology and the International Journal of Andrology have both independently established fine reputations of quality scientific publishing and are the top 2 journals in the field of andrology. Together they have laid an excellent foundation for Andrology to become a global leader in publishing studies of male reproductive health and science. We invite submission of all high-quality manuscripts, and will actively solicit reviews on cutting-edge topics from leading researchers. We encourage active participation in the journal by submitting top studies for publication, accepting review requests, and providing the editors with your ideas and suggestions.
No takes yet. Share an insight, caveat, or question.
Meistrich et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: